824 search results for “war on drug” in the Staff website
-
Faisal AiobiFaculty of Science
f.aiobi@lacdr.leidenuniv.nl | +31 71 527 6788
-
Suzanne WenkerFaculty of Science
s.a.m.wenker@lacdr.leidenuniv.nl | 071 5272727
-
Fouzia Lghoul-Oulad SaidFaculty of Science
f.lghoul@lacdr.leidenuniv.nl | +31 71 527 6582
-
Aida Naghilouye Hidaji
Faculty of Science
a.naghilouye.hidaji@lacdr.leidenuniv.nl | 071 5272727
-
Chenyu WangFaculty of Science
c.wang@lacdr.leidenuniv.nl | 071 5276211
-
Qinhao WuFaculty of Science
q.wu@lacdr.leidenuniv.nl | 071 5276211
-
Hidde van de BeekFaculty of Science
h.van.de.beek@lacdr.leidenuniv.nl | 071 5276211
-
Janneke LootensFaculty of Science
j.lootens@lacdr.leidenuniv.nl | 071 5276211
-
Asina GijasiFaculty of Science
a.gijasi@lacdr.leidenuniv.nl | +31 71 527 2727
-
Douwe BreimerFaculty of Science
ddbreimer@lacdr.leidenuniv.nl | 071 5272727
-
Marije OttoFaculty of Science
m.e.otto@lacdr.leidenuniv.nl | 071 5272727
-
Suruchi NepalFaculty of Science
s.nepal@lacdr.leidenuniv.nl | 071 5272727
-
Barbara ScalviniFaculty of Science
b.scalvini@lacdr.leidenuniv.nl | 071 5272727
-
Menno HoekstraFaculty of Science
hoekstra@lacdr.leidenuniv.nl | +31 71 527 6582
-
Joachim van GuyseFaculty of Science
j.f.r.van.guyse@lacdr.leidenuniv.nl | +31 71 527 4314
-
Amy HarmsFaculty of Science
a.c.harms@lacdr.leidenuniv.nl | +31 71 527 6326
-
Martijn MansonFaculty of Science
m.l.manson@lacdr.leidenuniv.nl | +31 71 527 6805
-
Zixuan WangFaculty of Science
z.wang01@lacdr.leidenuniv.nl | 071 5272727
-
Chunyuan YinFaculty of Science
c.yin@lacdr.leidenuniv.nl | 071 5272727
-
Sebastian TandarFaculty of Science
s.t.tandar@lacdr.leidenuniv.nl | 071 5272727
-
Dimitra EleftheriouFaculty of Science
d.eleftheriou@lacdr.leidenuniv.nl | 071 5272727
-
Eric BangFaculty of Science
e.n.bang@lacdr.leidenuniv.nl | 071 5272727
-
Jill de MolFaculty of Science
j.de.mol@lacdr.leidenuniv.nl | 071 5276051
-
Ilze BotFaculty of Science
i.bot@lacdr.leidenuniv.nl | +31 71 527 5682
-
Laura BosmansFaculty of Science
l.a.bosmans@lacdr.leidenuniv.nl | 071 5274378
-
Ming SunFaculty of Science
m.sun@lacdr.leidenuniv.nl | 071 5272727
-
Zhiyuan TanFaculty of Science
z.tan@lacdr.leidenuniv.nl | 071 5272727
-
Mengxu ZhangFaculty of Science
m.x.zhang@lacdr.leidenuniv.nl | 071 5276211
-
Jannik RouselFaculty of Science
j.rousel.2@umail.leidenuniv.nl | +31 71 527 2727
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Dutch Medicines Days
The FIGON Dutch Medicines Days is the conference where partners from industry, scientific and professional associations, universities, and government present their findings in the field of innovative drug research & development, share new scientific insights and results, exchange experiences and information,…
-
Micha DrukkerFaculty of Science
m.drukker@lacdr.leidenuniv.nl | +31 71 527 6271
-
Dongdong BiFaculty of Science
d.bi@lacdr.leidenuniv.nl | 071 5274245
-
Gerhard BurgerFaculty of Science
g.a.burger@lacdr.leidenuniv.nl | 071 5274285
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Master student Nicole ter Laak wins third “Dr. Saal van Zwanenberg research price”
Nicole ter Laak (Master student Biopharmaceutical sciences) has won the third price of the “Dr Saal van Zwanenberg research price”. The award ceremony is on 14 November.
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
Powerful new Leiden 'super antibiotic' may overcome resistance
The prestigious journal Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. ‘The idea was to tweak the original antibiotic and create a next-generation drug’, says Nathaniel Martin, professor…
-
One million euros grant for smart antibiotic combinations – tackling resistant infections and antimicrobial resistance
Optimised antibiotic combinations can combat bacteria more effectively while also slowing the development of resistance. Scientists from five European countries are joining forces to identify such combinations and provide tools for others to do the same. The project is led by Professor Coen van Hasselt…
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
Obesity and medication: when does bodyweight matter?
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and PhD researcher Koen van Rhee studied how obesity affects blood levels of two commonly used medicines. He also developed a method for pharmaceutical companies to test new drugs on this patient group.
-
Referral options
If you’re unsure where to refer students to for well-being support, this page should help. It provides an overview of the support available at Leiden University.
-
Gas Wars: A Two-Level Analysis of Ukraine’s Bargaining Position in the 2006 and 2009 Energy Conflicts with Russia
PhD defence
-
Freedom: what does it mean?
On 5 May we celebrate freedom, a basic human right that should not be taken for granted. We asked international students and staff what it means to them.
-
More research on side effects: ‘Side effects are not a side issue’
We need to be quicker and better at discovering side effects. In her inaugural lecture, Agnes Kant, Professor by Special Appointment of Innovation of Pharmacovigilance, calls for more research on these adverse effects.
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.